Frontlight ResearchEarly access
Pancreatic cancer trials in China
326 trials · From ClinicalTrials.gov, checked 16 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleA New Strategy for Preoperative Drainage of Resectable Pancreatic Head Cancer Combined Severe Obstructive Jaundice
- Where
- Shanghai
- Age
- 18 years to 75 years
- People
- 360
- Run by
- Ruijin Hospital
See details and how to joinNCT06541340 - Phase 2Taking peopleMilaberon in Advanced Solid Tumors: an Open, Multicenter Clinical Study
- Where
- Hangzhou
- Age
- 18 years to 65 years
- People
- 260
- Run by
- Zhejiang Provincial People's Hospital
See details and how to joinNCT06534762 - Phase 2Taking peopleAdebelimab Combined With Irinotecan Liposomal Injection, Oxaliplatin, Fluorouracil and Calcium Folinate Are Used in the First-line Treatment of Pancreatic Cancer Liver Metastasis Efficacy and Safety
- Where
- Shanghai
- Age
- 18 years to 75 years
- People
- 40
- Run by
- Jiang Long
See details and how to joinNCT06531278 - Phase 2Not yet taking people in ChinaSurufatinib Combined With Serplulimab and Standard Chemotherapy as First-line Treatment in Advanced Solid Tumors With Neuroendocrine Differentiation
- Where
- Shanghai
- Age
- 18 years to 75 years
- People
- 80
- Run by
- RenJi Hospital
See details and how to joinNCT06531291 - No phaseNot yet taking people in ChinaResearch of the Application of Artificial Intelligence Model "PANDA"
- Where
- Hangzhou
- People
- 200,000
- Run by
- Zhejiang University
See details and how to joinNCT06528223 - No phaseNot yet taking people in ChinaEarly Diagnosis of Pancreatic Cancer Via Deciphering Multi-modal Immunological Signatures
- Where
- Hangzhou
- People
- 3,000
- Run by
- Zhejiang University
See details and how to joinNCT06495749 - No phaseTaking peopleNALIRIFOX Combined With PD-1 Sequential Radiotherapy Versus AG Combined With PD-1 Sequential Radiotherapy as First-line Treatment of Locally Advanced Pancreatic Cancer
- Where
- Nanjing
- Age
- 18 years and over
- People
- 40
- Run by
- Du Juan
See details and how to joinNCT06494514 - Phase 2Taking peopleIvonescimab(AK112/SMT112) in Combination With Stereotactic Body Radiation Therapy and Chemotherapy in Patients With Pancreatic Cancer
- Where
- Wuhan
- Age
- 18 years and over
- People
- 36 worldwide
- Run by
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
See details and how to joinNCT06491472 · EU 2026-525831-17-00 - Phase 1/2Taking peoplePhase Ib/II Clinical Study of Adebrelimab in Combination With Decitabine, Albumin-bound Paclitaxel, and Gemcitabine for the First-line Treatment of Metastatic Pancreatic Cancer
- Where
- Tianjin
- Age
- 18 years to 75 years
- People
- 20
- Run by
- Tianjin Medical University Cancer Institute and Hospital
See details and how to joinNCT06454448 - No phaseTaking peopleEvaluate the Safety and Efficacy of BGT007H Cell Therapy in Patients With Relapsed/Refractory Pancreatic Cancer
- Where
- Shanghai
- Age
- 18 years to 75 years
- People
- 12
- Run by
- RenJi Hospital
See details and how to joinNCT06478225 - Phase 1Taking peopleGPC3/Mesothelin-CAR-γδT Cells Against Cancers
- Where
- Guangzhou
- Age
- 18 years to 75 years
- People
- 30
- Run by
- Second Affiliated Hospital of Guangzhou Medical University
See details and how to joinNCT06196294 - Phase 2/3Taking peopleTrans-Artery/Intra-Tumor Infusion of Checkpoint Inhibitors Plus Chemodrug for Immunotherapy of Advanced Solid Tumors
- Where
- Guanzhou
- Age
- 18 years and over
- People
- 200
- Run by
- Second Affiliated Hospital of Guangzhou Medical University
See details and how to joinNCT03755739 - Phase 1/2Taking peopleTriplex Checkpoint Inhibitors Therapy for Advanced Solid Tumors
- Where
- Guangzhou
- Age
- 18 years to 70 years
- People
- 100
- Run by
- Second Affiliated Hospital of Guangzhou Medical University
See details and how to joinNCT05187338 - Phase 1Taking peopleMesothelin/GPC3/GUCY2C-CAR-T Cells Against Cancers
- Where
- Guangzhou
- Age
- 18 years to 75 years
- People
- 30
- Run by
- Second Affiliated Hospital of Guangzhou Medical University
See details and how to joinNCT05779917 - Phase 2Taking peoplePD-1 Combined With Chemotherapy and PULSAR in LAPC and Local Recurrence Patients
- Where
- Shanhai
- Age
- 18 years to 75 years
- People
- 81
- Run by
- Fudan University
See details and how to joinNCT06359275 - Phase 2Taking peopleCentral-boost Ablative Radiation Therapy for Solid Tumors (CBART)
- Where
- Shanghai
- Age
- 18 years to 75 years
- People
- 67
- Run by
- Changhai Hospital
See details and how to joinNCT06427460 - Phase 2/3Not yet taking people in ChinaNimotuzumab Combined With GX as Postoperative Adjuvant Therapy in Pancreatic Cancer
- Where
- Tianjin
- Age
- 18 years to 75 years
- People
- 146
- Run by
- Tianjin Medical University Cancer Institute and Hospital
See details and how to joinNCT06409429 - Phase 4Taking peopleThe Study of Huaier Granule in Postoperative Adjuvant Therapy of Resectable Pancreatic Cancer
- Where
- Xi'an
- Age
- 18 years to 80 years
- People
- 642
- Run by
- Xi'an Jiaotong University
See details and how to joinNCT06368063 - Phase 1Taking peopleA Phase I Clinical Study of QLC1101 in Patients With Advanced Solid Tumors
- Where
- Guangzhou, Harbin, Kunming, Nanchang, Shanghai
- Age
- 18 years and over
- People
- 250
- Run by
- Qilu Pharmaceutical Co., Ltd.
See details and how to joinNCT06403735 - Phase 1/2Not yet taking people in ChinaNewly Emerging Immunotherapy for Pancreatic Cancer Treatment
- Where
- Shanghai
- Age
- 18 years to 75 years
- People
- 117
- Run by
- Fudan University
See details and how to joinNCT06370754 - Phase 2Taking peopleA Phase 2 Study of ABSK021 in Patients With Advanced Pancreatic Cancer
- Where
- Chengdu, Ha’erbin, Shanghai, Wuhan
- Age
- 18 years to 75 years
- People
- 82
- Run by
- Abbisko Therapeutics Co, Ltd
See details and how to joinNCT06111274 - Phase 2Not yet taking people in ChinaSurufatinib Combined With Gemcitabine Plus Nab-paclitaxel in Locally Advanced Pancreatic Cancer
- Where
- Wuhan
- Age
- 18 years to 75 years
- People
- 40
- Run by
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
See details and how to joinNCT06361030 - No phaseTaking peopleIrinotecan Liposome Combined With Oxaliplatin and Tegafur as Adjuvant Therapy for Pancreatic Cancer
- Where
- Nanjing
- Age
- 18 years to 75 years
- People
- 53
- Run by
- Kuirong Jiang
See details and how to joinNCT06361316 - Phase 1Not yet taking people in ChinaOncolytic Virus Plus Anti-PD1 and Chemotherapy as Preoperative Therapy for Patients With BRPC/LAPC
- Where
- Chengdu
- Age
- 18 years to 75 years
- People
- 20
- Run by
- Sichuan University
See details and how to joinNCT06346808 - Early phase 1Taking peopleStudy of Neoantigen mRNA Vaccines in Patients With Resectable Pancreatic Cancer
- Where
- Nanjing
- Age
- 18 years to 75 years
- People
- 12
- Run by
- Jinling Hospital, China
See details and how to joinNCT06326736